Cytogenetic analysis of 52 Indian patients with de novo myelodysplastic syndromes - A comparative analysis of results with reports from Asia

Annals of Hematology

Volumn 84, Issue 5, 2005, Pages 298-303

  Dakshinamurthy, Amirtha Ganesh ^a   Novitzky, Nicolas ^a   Bharadwaj, Raghva ^b   Prakhya, Balakrishna Murthy ^c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b GOVERNMENT GENERAL HOSPITAL   (India)

^c International Institute of Biotechnology and Toxicology   (India)

Author keywords

Cytogenetics; Indian population; Myelodysplastic syndromes

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGE DISTRIBUTION; ARTICLE; ASIA; CHINESE; CHROMOSOME 10Q; CHROMOSOME 17; CHROMOSOME 20Q; CHROMOSOME 5; CHROMOSOME 5Q; CHROMOSOME 7; CHROMOSOME 7Q; CHROMOSOME 8; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME BANDING PATTERN; CHROMOSOME DELETION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; INCIDENCE; INDIAN; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MORBIDITY; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; SEX DIFFERENCE; ADOLESCENT; AGED; ASIAN; CHILD; ETHNOLOGY; GENETICS; HUMAN CHROMOSOME; INDIA; INFANT; KARYOTYPING; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; PREVALENCE;

ADOLESCENT; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; FEMALE; HUMANS; INDIA; INFANT; INFANT, NEWBORN; KARYOTYPING; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PREVALENCE;

EID: 23244466657     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-004-0997-x     Document Type: Article

References (38)

1. Aul C, Gattermann N, Schneider W (1992) Age-related incidence and other epidemiological aspects of myelodysplastic syndromes. Br J Haematol 82:358-367
2. Aul C, Giagounidis A, Germing U (2001) Epidemiological features of myelodysplastic syndromes: Results from regional cancer surveys and hospital-based statistics. Int J Hematol 73:405-410
3. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1982) The French-American-British cooperative group. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51:189-199
4. Bernasconi P, Alessandrino EP, Boni M, Bonfichi M, Morra E, Lazzarino M, Campagnoli C, Astori C (1994) Karyotype in myelodysplastic syndromes: relation to morphology, clinical evolution and survival. Am J Hematol 46:270-277 1:STN:280:ByuA3M7islI%3D
5. Billstrom R, Thiede, T, Hansen S, Heim S, Kristoffersson U, Mandahl N, Mitelman F (1988) Bone marrow karyotype and prognosis in primary myelodysplastic syndromes. Eur J Haematol 41:341-346
6. Chan LC, Kwong YL, Liu HW, Chan TK, Todd D, Ching LM (1992) Cytogenetic analysis of hematologic malignancies in Hong Kong. Cancer Genet Cytogenet 62:154-159
7. Cunningham I, MacCallum SJ, Nicholls MD, Byth K, Hewson JW, Arnold B, Motum PI, Mulligan S, Crane GG (1995) The myelodysplastic syndromes: An analysis of prognostic factors in 226 cases from a single institution. Br J Haematol 90:602-606
8. Davico L, Sacerdote C, Ciccone G (1998) Chromosome 8, occupational exposures, smoking, and acute nonlymphocytic leukemias: A population-based study. Cancer Epidemiol Biomark Prev 7:1123-1125
9. Goasguen JE, Garand R, Bizet M, Bremond JL, Gardais J, Callat MP, Accard F, Chaperon J (1990) Prognostic factors of myelodysplastic syndromes - a simplified 3-D scoring system. Leuk Res 14:255-262
10. Greenberg PL (2001) Implications of pathogenetic and prognostic features for management of myelodysplastic syndromes. Lancet 357:1059-1060
11. Heim S, Mitelman F (1986) Chromosome abnormalities in the myelodysplastic syndromes. Clin Hematol 15:1003-1021
12. Intragumtornchai T, Prayoonwiwat W, Swasdikul D, Suwanwela N, Chaimongkol B, Jootar S, Chansung K, Chancharunee S, Leelasiri A, Yoshida Y (1998) Myelodysplastic syndromes in Thailand: A retrospective pathologic and clinical analysis of 117 cases. Leuk Res 22:453-460
13. Jacobs RH, Cornbleet MA, Vardiman JW, Larson RA, LeBeau MM, Rowley JD (1986) Prognostic significance of morphology and karyotype in primary myelodysplastic syndromes. Blood 67:1765-1772
14. Johansson B, Mertns F (1991) Geographic heterogeneity of neoplasia-associated chromosome aberrations. Genes Chromosomes Cancer 3:1-7
15. Juneja SK, Imbert M, Jouault H, Scoazec JY, Sigaux F, Sultan C (1983) Haematological features of primary myelodysplastic syndromes (PMDS) at initial presentation: A study of 118 cases. J Clin Pathol 36:1129-1135
16. Kadam P, Dadabhoy K, Bishey A, Athale U, Nair C, Nair R, Advani S (1995) Chromosome investigations and clinical outcome in patients with myelodysplastic syndromes. Indian J Med Res 101:163-169
17. Lee JJ, Kim HJ, Chung IJ, Kim JS, Sohn SK, Kim BS, Lee KH, Kwak JY, Park YH, Ahn JS, Park YS (1999) Comparisons of prognostic scoring systems for myelodysplastic syndromes: A Korean multicenter study. Leuk Res 23:425-432
18. Mansoor AM, Bharadwaj TPR, Sethuraman S, Chandy M, Pushpa V, Kamada N, Bala Krishna Murthy P (1993) Analysis of karyotype, SCE, and point mutation of RAS oncogene in Indian MDS patients. Cancer Genet Cytogenet 55:12-20
19. Mitelman F (1986) Geographic heterogeneity of chromosome aberrations in hematologic disorders. Cancer Genet Cytogenet 20:203-208
20. F Mitelman 1991 ISCN: An International System for Human Cytogenetic Nomenclature Karger Basel
21. Nisse C, Lorthois C, Dorp V, Eloy E, Haguenoer JM, Fenaux P (1995) Exposure to occupational and environmental factors in myelodysplastic syndromes. Preliminary results of a case-control study. Leukemia 9:693-699
22. Nowell PC, Besa EC, Stelmach T, Finan JB (1986) Chromosome studies in preleukemic states. V. Prognostic significance of single versus multiple abnormalities. Cancer 58:2571-2575
23. Oguma S, Yoshida Y, Uchino H, Maekawa T, Nomura T, Mizoguchi H (1995) Clinical characteristics of Japanese patients with primary myelodysplastic syndromes: A co-operative study based on 838 cases. Leukemia 19:219-225
24. Parlier V, van Melle G, Beris P, Schmidt PM, Tobler A, Haller E, Jotterand-Bellomo M (1994) Hematologic, clinical and cytogenetic analysis of 109 patients with primary myelodysplastic syndrome: prognostic significance of morphology and chromosome findings. Cancer Genet Cytogenet 78:219-231
25. Paydas S, Kocak R (1996) Younger age observation in myelodysplastic syndrome. Leuk Res 20:367
26. Pfeilstocker M, Reisner R, Nooslinger T, Gruner H, Nowotny H, Tuchler H, Schlogl E, Pittermann E, Heinz R (1999) Cross-validation of prognostic scores in myelodysplastic syndromes on 386 patients from a single institution confirms importance of cytogenetics. Br J Haematol 106:455-463
27. Shimizu H, Matsushita Y, Aoki K, Nomura T, Yoshida Y, Mizoguchi H (1995) Prevalence of the myelodysplastic syndromes in Japan. Int J Hematol 61:17-22
28. Sole F, Espinet B, Sanz GF, Cerrera J, Calasanz MJ, Luke E, Prieto F, Granada I, Hernandez JM, Cigudosa JC, Diez JL, Buke E, Marques ML, Arranz E, Rios R, Cliument JAM, Vallespi T, Florensa L, Woessner S (2000) Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Br J Haematol 108:346-356
29. Stillman WS, Varella-Garcia M, Irons RD (2000) The benzene metabolite, hydroquinone, selectively induces 5q31 and -7 in human CD34 + CD19 bone marrow cells. Exp Hematol 28:169-176
30. Suciu S, Kuse R, Weh HJ, Hossfeld DK (1990) Results of chromosome studies and their relation to morphology, course and prognosis in 120 patients with de novo myelodysplastic syndrome. Cancer Genet Cytogenet 44:15-26
31. Tien HF, Wang CH, Chuang SM (1994) Cytogenetic studies, ras mutation, and clinical characteristics in primary myelodysplastic syndromes: A study on 68 Chinese patients in Taiwan. Cancer Genet Cytogenet 74:40-49
32. Toyama K, Ohyashiki K, Yoshida Y, Abe T, Asanso S, Hirai H, Hirashima K, Hotta T, Kuramoto A, Kuriya S, Miyazaki T, Kakishita E, Mizoguchi H, Okada M, Shirakawa S, Takaku F, Tomanaga M, Uchino H, Yasunaga K, Nomura T (1993) Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: A multicentric study in Japan. Leukemia 7:499-508
33. Verhoef GEG, Boogaerts MA (1996) Cytogenetics and its prognostic value in myelodysplastic syndromes. Acta Haematol 95:95-101
34. White AD, Culligan DJ, Hoy TG, Jacobs A (1992) Extended cytogenetic follow-up of patients with myelodysplastic syndrome (MDS). Br J Haematol 81:499-502
35. Yoshida Y, Oguma S, Uchino H, Maekawa T (1987) Clinical features and prognosis of refractory myelodysplastic anaemia. A Japanese co-operative study. Acta Haematol Jpn 50:37-50
36. Yunis JJ, Rydell RE, Oken MM, Arnese MA, Mayer MG, Lobell M (1986) Refined chromosome analysis as an independent prognostic indicator in de novo myelodysplastic syndromes. Blood 67:1721-1730
37. Yunis JJ, Lobell M, Arnesen MA, Oken MM, Mayers MG, Rydell RE, Brunning RD (1988) Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia. Br J Haematol 68:189-194
38. Zhao WL, Xu L, Wu W, Yan H, Tang W, Hu J, Chen Y, Li JM, Zeng XY, Xiong SM, Shen ZX, Chen Z, Wang ZY, Chen AJ (2002) The myelodysplastic syndromes: Analysis of prognostic factor and comparison of prognostic systems in 128 Chinese patients from a single institution. Haematol J 3:137-]144